While the body produces its own supply, factors like aging, environmental pollutants, and daily stress can deplete these levels
The rise of unregulated black market injections poses severe risks to UK patients, including contaminated vials or incorrect concentrations that lead to avoidable hospitalisations
Your dose may increase during treatment, but your price stays the same
Customizing GLP-1 medication dosages for patients with chronic kidney disease (CKD) is a critical step to ensure treatments are both safe and effective
There have been lawsuits filed against Novo Nordisk, the maker of both drugs, accusing the company of failing to warn patients about the risk of an eye injury known as NAION
Age plays less of a role before menopause